Prescription medication · Disease-Modifying Antirheumatic Drug (DMARD)
sulfasalazine
Also sold as Azulfidine. Sulfasalazine treats ulcerative colitis, a condition that causes inflammation and sores in the lining of the large intestine.
Data updated 2026-05-15
- 76,270
- FDA reportsOften reported
- 7
- InteractionsFew interactions
- $0.18
- Generic price (NADAC)
What the data shows
sulfasalazine (Azulfidine) is a prescription Disease-Modifying Antirheumatic Drug (DMARD), more reported than most tracked drugs (76,270 FDA reports), with 7 documented drug interactions.
Reporting volume reflects how widely a drug is used and studied, not how dangerous it is, a FAERS report documents a temporal association, never proof of cause.
sulfasalazine (Azulfidine) is a prescription Disease-Modifying Antirheumatic Drug (DMARD). Sulfasalazine treats ulcerative colitis, a condition that causes inflammation and sores in the lining of the large intestine.
Sulfasalazine is a drug that reduces inflammation in the body. It is used to treat ulcerative colitis.
Verify with FDA → · CMS NADAC pricing →
Drug Pricing (NADAC)
Generic Price
$0.18/unit
Generic Available
Yes (5 manufacturers)
Pricing data from NADAC (CMS), effective December 18, 2024. Compare all drug costs →
NADAC price trail: SULFASALAZINE 500 MG TABLET
Same CMS presentation as the headline generic unit price above (3 effective dates). Adjacent % compares consecutive NADAC releases for this description only, not a patient out-of-pocket quote. Latest step: +4.4% vs prior release.
| Effective | NADAC / unit | vs prior | NDCs |
|---|---|---|---|
| April 17, 2024 | $0.1285/EA | - | 2 |
| November 20, 2024 | $0.1711/EA | +33.2% | 1 |
| December 18, 2024 | $0.1786/EA | +4.4% | 10 |
What it does
Sulfasalazine treats ulcerative colitis, a condition that causes inflammation and sores in the lining of the large intestine.
Common side effects
Loss of appetite, Headache, Nausea
Key warnings
You should not take this medicine if you have a blockage in your intestines or urinary tract.
The sections below are summarized in plain English from sulfasalazine's FDA-approved prescribing information. They describe what the official label says, and are not personal medical advice.
How It Works
Sulfasalazine is an anti-inflammatory drug. It works by reducing inflammation in the colon. The exact way it does this is not fully known.
Side Effects (from patient reports)
Based on 76,270 FDA adverse event reports.
Most-reported reactions
Adverse reactions in FAERS for sulfasalazine, by number of reports
- Rheumatoid Arthritis
Rheumatoid Arthritis
19,190 reports
- Pain
Pain
15,658 reports
- Arthralgia
Arthralgia
13,161 reports
- Fatigue
Fatigue
13,017 reports
- Joint Swelling
Joint Swelling
12,481 reports
- Rash
Rash
10,678 reports
- Abdominal Discomfort
Abdominal Discomfort
9,801 reports
- Contraindicated Product Administered
Contraindicated Product Administered
9,454 reports
- Condition Aggravated
Condition Aggravated
9,374 reports
- Alopecia
Alopecia
9,277 reports
What this shows Bars show how often each reaction was reported, not how likely it is to happen, a report records a temporal association, never proof that the drug caused it.
Reports over time
Adverse-event reports filed for sulfasalazine each year to the FDA Adverse Event Reporting System (FAERS).
Year-to-year volume tracks usage, prescribing, and scrutiny, not a change in per-patient risk. Source: FDA FAERS.
Where sulfasalazine sits
sulfasalazine has more FDA adverse-event reports than 82% of the drugs FAERS tracks. A high position reflects how widely a drug is used and watched, not how dangerous it is.
Percentile across all drugs PlainMeds tracks by FAERS report volume. The dot is sulfasalazine; the line is the median (50th percentile).
FDA Adverse Event Report Analysis
Detailed analysis of 76,270 reports from the FDA Adverse Event Reporting System (FAERS). Reports span 2003–2025.
Total Reports
76,270
Reports Mentioning Death
6,629
8.7% of reports — not proof of cause
Hospitalization Reports
20,613
Top Indication
Rheumatoid Arthritis
Gender Distribution
Age Distribution
Most Reported Adverse Reactions (FAERS)
| # | Reaction | Reports |
|---|---|---|
| 2 | RHEUMATOID ARTHRITIS | 19,190 |
| 3 | PAIN | 15,658 |
| 5 | ARTHRALGIA | 13,161 |
| 6 | FATIGUE | 13,017 |
| 7 | JOINT SWELLING | 12,481 |
| 9 | RASH | 10,678 |
| 10 | ABDOMINAL DISCOMFORT | 9,801 |
| 11 | CONTRAINDICATED PRODUCT ADMINISTERED | 9,454 |
| 12 | CONDITION AGGRAVATED | 9,374 |
| 13 | ALOPECIA | 9,277 |
| 14 | ARTHROPATHY | 9,001 |
| 15 | SYNOVITIS | 8,965 |
| 16 | TREATMENT FAILURE | 8,687 |
| 17 | SYSTEMIC LUPUS ERYTHEMATOSUS | 8,588 |
| 18 | SWELLING | 8,508 |
Reactions in Death Reports
Reactions in Hospitalization Reports
Source: FDA FAERS (Adverse Event Reporting System) Reports are voluntary and do not establish causation
Serious Warnings
You should not take this medicine if you have a blockage in your intestines or urinary tract. You should not take this medicine if you have porphyria, as it could cause an attack. You should not take this medicine if you are allergic to sulfasalazine, its ingredients, sulfonamides, or salicylates.
Known Drug Interactions
Drugs That May Cause Methemoglobinemia When Used with LIDODERM Patients who are administered local anesthetics are at increased risk of developing methemoglobinemia when concurrently exposed to the following drugs, which could include other local anesthetics: Examples of Drugs Associated with Methemoglobinemia : Class Examples Nitrates/Nitrites nitric oxide, nitroglycerin, nitroprusside, nitrous oxide Local anesthetics articaine, benzocaine, bupivacaine, lidocaine, mepivacaine, prilocaine, procaine, ropivacaine, tetracaine Antineoplastic agents cyclophosphamide, flutamide, hydroxyurea,...
Mechanism: Both drugs can cause a rare blood problem that prevents oxygen from reaching your body's tissues. Using them together makes this dangerous side effect more likely to happen.
Coadministration of VOSEVI with BCRP substrates (e.g., methotrexate, mitoxantrone, imatinib, irinotecan, lapatinib, rosuvastatin, sulfasalazine, topotecan) is not recommended [see Clinical Pharmacology (12.3) ].
Mechanism: This medicine interferes with a protein that transports sulfasalazine, which could cause the levels of sulfasalazine in your body to rise.
John's Wort, sucralfate, sulfasalazine Measure serum digoxin concentrations before initiating concomitant drugs.
Mechanism: Sulfasalazine can decrease the amount of digoxin in your blood, making the heart medicine less effective.
7.5 Effects of Other Drugs on Folates Several drugs have been reported to reduce folate concentrations by inhibition of the dihydrofolate reductase enzyme (e.g., methotrexate and sulfasalazine) or by reducing folate absorption (e.g., cholestyramine), or via unknown mechanisms (e.g., antiepileptics such as carbamazepine, phenytoin, phenobarbital, primidone and valproic acid).
Mechanism: Sulfasalazine can lower the levels of folate in your body by blocking a specific enzyme that helps process it.
7.4 Sulfasalazine Patients in a clinical study who were on established therapy with sulfasalazine, to which Enbrel was added, were noted to develop a mild decrease in mean neutrophil counts in comparison to groups treated with either Enbrel or sulfasalazine alone.
Mechanism: Taking these two medicines together can lower the number of white blood cells that help your body fight infections.
This is a plain-language summary of FDA-label interaction records and does not provide individual medication-combination directions.
Common Questions
Can I take this with food?
What if I have stomach upset?
How long will I need to take this medicine?
Can this medicine affect my ability to have children?
What should I do if I think I'm having an allergic reaction?
Can I take other medicines with Sulfasalazine?
Will this medicine cure my ulcerative colitis?
How long does it take for this medicine to work?
Can this medicine cause my urine to change color?
Is it safe to get vaccines while taking Sulfasalazine?
What are the common side effects of sulfasalazine?
Does sulfasalazine interact with other medications?
What drug class is sulfasalazine?
What pregnancy or breastfeeding source fields are listed for sulfasalazine?
Related Medications in Disease-Modifying Antirheumatic Drug (DMARD)
Other drugs grouped near sulfasalazine - same-class peers and common alternatives.
abatacept
Orencia
Orencia is a medicine that helps to reduce inflammation.
Compare with sulfasalazine →
acetaminophen
Tylenol
Acetaminophen (Tylenol) is a medicine that can relieve pain and reduce fever.
Compare with sulfasalazine →
acetaminophen/hydrocodone
Vicodin, Norco
This medicine contains acetaminophen and hydrocodone.
Compare with sulfasalazine →
acetaminophen/oxycodone
Percocet
Percocet is a strong pain medicine.
Compare with sulfasalazine →
adalimumab
Humira
Idacio is a medicine that blocks a protein called TNF.
Compare with sulfasalazine →
Compare beyond drug class
Nationwide peers by FAERS volume & death-report share
Two PlainMeds-derived comparison paths for sulfasalazine: nearest FDA FAERS report volume and nearest death-report share among drugs with at least 1,000 logged reports, excluding same-class neighbors listed above. Counts reflect reporting volume, not proven individual harm.
Similar FAERS report volume
Nearest drugs by total FAERS reports. This record: 76,270.
Similar death-report share
Nearest drugs by FAERS death-report share. This record: 8.69%.
- primidone Δ 0.00 pts · 9,782 reports · Anticonvulsant (Barbiturate) 8.69%death share
- clarithromycin Δ 0.00 pts · 33,247 reports · Macrolide Antibiotic 8.69%death share
- finasteride Δ 0.02 pts · 56,567 reports · 5-Alpha Reductase Inhibitor 8.68%death share
- artificial tears Δ 0.04 pts · 2,450 reports · Ocular Lubricant 8.65%death share
Medication Guides
Understanding Drug Interactions
How CYP450 enzymes, inhibitors, and inducers affect your medications
Generic vs Brand Name Drugs
FDA requirements, cost savings, and when the difference matters
Narrow Therapeutic Index Drugs
FDA bioequivalence and label-record context for narrow therapeutic index medicines
Common Drug Interactions
Dangerous medication combinations and how to protect yourself
Save on sulfasalazine
Compare prices and find discounts at pharmacies near you. Free coupons can save up to 80% on prescriptions.
Disclosure: This link may earn us a commission at no extra cost to you. See our terms.
What the FDA Data Shows for sulfasalazine
The FDA label for sulfasalazine (sold under brand names such as Azulfidine) classifies it as a prescription-only medication in the Disease-Modifying Antirheumatic Drug (DMARD) class. Sulfasalazine treats ulcerative colitis, a condition that causes inflammation and sores in the lining of the large intestine. Official labeling lists 6 commonly reported side effects, including Loss of appetite, Headache, Nausea.
Post-market surveillance from the FDA Adverse Event Reporting System (FAERS) captures real-world experience. For this drug, FAERS contains 76,270 voluntary reports. The database also lists 7 documented drug interactions derived from FDA labeling, with the top-flagged interaction rated moderate severity. NADAC pricing from CMS shows a generic unit cost of $0.18.
Report counts do not establish causation, a FAERS entry documents a temporal association, not proof that the drug produced the outcome. Widely prescribed medications naturally accumulate more reports than niche therapies, so raw totals must be interpreted alongside total exposure. Shortage status, recall history, and patent information are separate source-record fields. This page is a public FDA/CMS registry and does not provide medical, treatment, substitution, or medication-change directions.
Data Sources
Drug labeling: FDA Drug Labels (SPL/DailyMed). Adverse events: FDA Adverse Event Reporting System (FAERS). Pricing: CMS National Average Drug Acquisition Cost (NADAC).
FAERS reports are voluntary and do not establish causation. Drug interactions are derived from FDA labeling and clinical references. This registry does not provide medication decisions.
Last updated: December 12, 2022
PlainMeds is rendered directly from FDA openFDA/FAERS extracts, DailyMed labels, and CMS drug-pricing files, no number is typed in by an editor. FAERS counts, recalls, shortages, and price figures on this page are queried live from those federal extracts. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-05-15. Primary sources: openFDA / FAERS, DailyMed and CMS Part B ASP.
Read our methodology - how this data is sourced, computed, and verified.
Data currency: FDA FAERS adverse-event reports through 2025, CMS NADAC acquisition-cost pricing effective December 2024, compiled from the source snapshot dated . See our methodology for per-source dates and refresh cadence. Spot a figure that looks wrong? Report a data issue.
All federal data sources used on this page
- FDA Orange Book - approved drug products with therapeutic equivalence. accessdata.fda.gov/cder/ob
- FDA DailyMed - NIH-hosted drug labeling for FDA-approved meds. dailymed.nlm.nih.gov
- FDA Adverse Event Reporting System (FAERS) - post-marketing safety surveillance. fda.gov/drugs/faers
- NLM RxNorm - standardized clinical drug nomenclature. nlm.nih.gov/research/umls/rxnorm
- CMS Medicare Part B Drug Average Sales Price Files - federal drug pricing data. cms.gov/medicare/part-b-drugs/asp
- FDA Drug Shortages Database - current and resolved drug shortage tracking. accessdata.fda.gov/drugshortages